Effect of decaspiride on the immunosuppressive action of prednisone, dexamethasone and cyclophosphamide
Chiariello, M.; Sardi, B.; Piacenza, G.; Pesce, E.
Bollettino Chimico Farmaceutico 117(5): 280-288
1978
ISSN/ISBN: 0006-6648 PMID: 33686 Document Number: 126847
Document emailed within 1 workday
Related Documents
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958Paczek, L.; Gaciong, Z.; Górski, A.; Lagodziński, Z.; Brzezny, M. 1989: TFX modulates the immunosuppressive effect of cyclophosphamide on antibody production in mice Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 415-419
El-On, J.; Greenblatt, C.L. 1971: The effect of the immunosuppressive agent cyclophosphamide on IgG levels and parasite number in experimental trypanosomiasis Israel Journal of Medical Sciences 7(11): 1294-1298
Arai, Y.; Tanooka, H.; Sekine, T.; Fukuoka, F. 1971: Effect of immunosuppressive agents on antitumor action of lentinan Gan 62(2): 131-134
Matl, I.; Lácha, J.; Lodererová, A.; Símová, M.; Teplan, V.; Lánská, V.; Vítko, S. 2000: Withdrawal of prednisone from a triple combination of immunosuppressive agents after kidney transplantation Casopis Lekaru Ceskych 139(4): 115-119
Flores, M.; Gudiño Pérez, R.; Ríos Prado, R.; Almedia Arvizu, V.M.; Castrejón Vázquez, M.I.; Ocampo, A.A. 2001: Comparative study of the treatment of autoimmune uveitis with prednisone and with cyclophosphamide and azathioprine Revista Alergia Mexico 48(3): 75-79
Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Shih, W.W.; Baumhefner, R.W.; Tourtellotte, W.W.; Haskell, C.M.; Korn, E.L.; Fahey, J.L. 1983: Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis Clinical and Experimental Immunology 53(1): 122-132
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Tirelli, U.; Carbone, A.; Veronesi, A.; Galligioni, E.; Trovò, M.G.; Tumolo, S.; Grigoletto, E. 1982: Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides Cancer Treatment Reports 66(1): 167-169
Thornes, R.D.; Early, A.M.; Hogan, B.L.; Reen, D. 1982: Chronic brucellosis--clinical response to reduction of suppressor T lymphocytes by cyclophosphamide/prednisone Irish Medical Journal 75(11): 423-424
Wilson, K.; Shelley, W.; Belch, A.; Brandes, L.; Bergsagel, D.; Klimo, P.; White, D.; Willan, A. 1987: Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma Cancer Treatment Reports 71(10): 981-982
Pallardo, L.M.; Sanchez, J.; Garcia, J.; Moreno, R.F.; Rochera, A.; Cabezuelo, J. 1988: Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity Transplantation Proceedings 20(5 Suppl 6: 26-27
Sheĭko, E.A.; Shikhliarova, A.I. 2011: Effect of monochromatic red lighting potentiating antitumor action of cyclophosphamide injected with autoblood Voprosy Onkologii 57(4): 493-496
Okubo, M.; Chen, X.M.; Kamata, K.; Masaki, Y.; Uchiyama, T. 1986: Immunosuppressive effect and mode of action of cyclosporin a (Cy A) and mizoribine (MZR) on humoral immune response in mice Nihon Jinzo Gakkai Shi 28(1): 51-59
Silver, R.M.; Warrick, J.H.; Kinsella, M.B.; Staudt, L.S.; Baumann, M.H.; Strange, C. 1993: Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease Journal of Rheumatology 20(5): 838-844
Brun, B.; Kuentz, M.; Man, N.G.; Feuilhade, F.; Bierling, P.; Vernant, J.P.; Farcet, J.P.; Cordonnier, C.; Reyes, F.; Dreyfus, B.; Rochant, H. 1983: Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases Presse Medicale 12(19): 1205-1210
Appelhans, M.; Bonsmann, G.; Orge, C.; Bröcker, E.B. 1993: Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 44(3): 143-147
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Whitecar, J.P.; Bodey, G.P.; Freireich, E.J.; McCredie, K.B.; Hart, J.S. 1972: Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults Cancer ChemoTherapy Reports 56(4): 543-550